GCTHomo sapiens (Human)Cancer cell line

Also known as: University of Rochester-Human Cell Line-1, UR-HCL-1, Giant Cell Tumor

🤖 AI SummaryBased on 7 publications

Quick Overview

Human cell line from malignant fibrous histiocytoma

Detailed Summary

The GCT cell line was derived from a lung metastasis of a malignant fibrous histiocytoma. It exhibits a high degree of chromosomal instability with a modal chromosome number of 59. The cell line shows multiple numerical and structural chromosome changes, including marker chromosomes. A putative clone, NAD-GCT, was identified with a modal number of 41, consisting exclusively of acrocentric chromosomes, indicating a mouse origin. These characteristics highlight the genetic complexity and potential for contamination in cancer cell lines.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1229
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age29
Age CategoryAdult
SexMale

Disease Information

DiseaseUndifferentiated pleomorphic sarcoma
LineageSoft Tissue
SubtypeUndifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma
OncoTree CodeMFH

DepMap Information

Source TypeATCC
Source IDACH-000835_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Gln317Ter (c.948_949delinsTT) (c.948_949CC>TT)Heterozygous-from parent cell line GCT
MutationSimpleTP53p.Arg248Trp (c.742C>T)HomozygousSomatic mutation acquired during proliferationfrom parent cell line VCaP
MutationSimpleCDKN2Ap.Leu32Arg (c.95_96TG>GT)Homozygous-from parent cell line GCT
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
11,12
D16S539
9
D18S51
17,19
D19S433
14
D21S11
28
D2S1338
17,18
D3S1358
16,17
D5S818
13,15
D7S820
11,12
D8S1179
11,13
FGA
21
Penta D
12
Penta E
12,13
TH01
8,9.3
TPOX
8,9
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Mutations of the BRAF gene in human cancer.";

Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

Nature 417:949-954(2002).

Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire.

Gasson J.C., Abboud C.N.

Exp. Hematol. 21:1342-1352(1993).

Fibrous histiocytoma cell line: chromosome studies of mouse and man.";

Hecht F., Berger C.S., Kaiser-McCaw Hecht B., Speiser B.L.

Cancer Genet. Cytogenet. 8:359-362(1983).

Human cell lines that elaborate colon-stimulating activity for the marrow cells of man and other species.

DiPersio J.F., Brennan J.K., Lichtman M.A., Speiser B.L.

Blood 51:507-519(1978).